🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a single center, open-label, fixed sequence Phase 1, drug-drug inte...
Status
Completed
Location
ICON Early Phase Services
Start Date
2022-04-26
Trial ID
NCT05334108
CAROTID-STABILISE is a phase III, multicentre, randomised, double-blind, pl...
Status
Not Yet Recruiting
Location
Alexandria University, Smouha University Comprehensive Stroke Center
Start Date
2027-07
Trial ID
NCT07586540
Treatments Being Tested
Primary Objective: To compare the efficacy of alirocumab (Praluent®) with ...
Status
Completed
Location
Investigational Site Number 392026
Start Date
2016-11-15
Trial ID
NCT02984982
This is a single center, open-label, fixed sequence Phase 1, drug-drug inte...
Status
Terminated
Location
Syneos Health Clinical Research Services, LLC.
Start Date
2021-02-18
Trial ID
NCT04764851
The purpose of this open-label, 2-period, fixed-sequence study is to charac...
Status
Completed
Location
Clinical Pharmacology of Miami ( Site 0001)
Start Date
2018-03-01
Trial ID
NCT03311841
Primary Objective: To collect real-use (usability) data assessing the robu...
Status
Completed
Location
Investigational Site Number 8400024
Start Date
2018-03-29
Trial ID
NCT03415178
Primary Objective: To evaluate the efficacy of alirocumab (75 or 150 milli...
Status
Completed
Location
Investigational Site Number 0760001
Start Date
2018-08-31
Trial ID
NCT03510715